Share your experiences using CAR T-cell therapy in patients with hematologic malignancies, particularly BCMA-targeted therapies, with the Oncology Nursing Society (ONS) during a series of two three-hour virtual focus groups in March 2023. During the discussions in the focus groups, participants will help ONS identify and assess the key nursing issues, trends, and barriers related to the use of CAR T-cell therapy in hematologic malignancies and identify strategies to support oncology nurses in clinical practice. Participants will also explore healthcare equity for those eligible for CAR T-cell therapy. The focus groups are produced by ONS and supported by funding from Janssen Oncology/Legend Biotech.
ONS will select approximately 15 nurses to meet via a video conferencing platform to participate in active discussions and brainstorming. Each participant receives a $1,000 honorarium on completion of both focus groups.
If you are interested in participating, please complete this brief survey by February 3, 2023, to determine your eligibility: https://research.zarca.com/r/fj7nwA. Selected participants will be notified by email no later than February 7, 2023.
Please contact Kimberly Rivera at email@example.com or Kirstin Repco at firstname.lastname@example.org with any questions. Thank you for your support.